New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Enabled by a plethora of new technologies, research in membrane transporters has exploded in the past decade. The goal of this state‐of‐the‐art article is to describe recent advances in research on membrane transporters that are particularly relevant to drug discovery and development. This review covers advances in basic, translational, and clinical research that has led to an increased understanding of membrane transporters at all levels. At the basic level, we describe the available crystal structures of membrane transporters in both the solute carrier (SLC) and ATP binding cassette superfamilies, which has been enabled by the development of cryogenic electron microscopy methods. Next, we describe new research on lysosomal and mitochondrial transporters as well as recently deorphaned transporters in the SLC superfamily. The translational section includes a summary of proteomic research, which has led to a quantitative understanding of transporter levels in various cell types and tissues and new methods to modulate transporter function, such as allosteric modulators and targeted protein degraders of transporters. The section ends with a review of the effect of the gut microbiome on modulation of transporter function followed by a presentation of 3D cell cultures, which may enable in vivo predictions of transporter function. In the clinical section, we describe new genomic and pharmacogenomic research, highlighting important polymorphisms in transporters that are clinically relevant to many drugs. Finally, we describe new clinical tools, which are becoming increasingly available to enable precision medicine, with the application of tissue‐derived small extracellular vesicles and real‐world biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Mapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Self-citationKanai, M., Akiyama, M., Takahashi, A., Matoba, N., Momozawa, Y., Ikeda, M., Iwata, N., Ikegawa, S., Hirata, M., Matsuda, K., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0047-6 · Cited by 801
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704
Vatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632
Reproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
PEPPERCORN, M. A., & GOLDMAN, P. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29238-2 · Cited by 450
Endosomes are specialized platforms for bacterial sensing and NOD2 signalling
Nakamura, N., Lill, J. R., Phung, Q., Jiang, Z., Bakalarski, C., de Mazière, A., Klumperman, J., Schlatter, M., Delamarre, L., & Mellman, I. (2014) · Nature · doi:10.1038/nature13133 · Cited by 313
SLC25A51 is a mammalian mitochondrial NAD(+) transporter
Luongo, T. S., Eller, J. M., Lu, M.-J., Niere, M., Raith, F., Perry, C., Bornstein, M. R., Oliphint, P., Wang, L., McReynolds, M. R., et al. (2020) · Nature · doi:10.1038/s41586-020-2741-7 · Cited by 308 · cited 1×
“64 Commonly used methods to determine the localization of mitochondrial transporters are to cotransfect a GFP chimera transporter cDNA with the cDNA of the mitochondrial marker, COX8(65) and determine the transporter expression levels after isolating mitochondrial fractions.(66) Mutations in mitochondrial transporters…”
MethodKostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262
Global Genetic Networks and the Genotype-to-Phenotype Relationship
Costanzo, M., Kuzmin, E., van Leeuwen, J., Mair, B., Moffat, J., Boone, C., & Andrews, B. (2019) · Cell · doi:10.1016/j.cell.2019.01.033 · Cited by 241 · cited 1×
“For example, the RESOLUTE Consortium(41) deorphaned SLC25A51 using a genetic interactions approach to infer gene function in a “guiltby- association” principle.(42,43) The group used the human cell line HAP1, where the isogenic cell lines lacking 1 of 141 highly expressed SLC genes were combined with a CRISPR/Cas9 lib…”
MethodCryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states
Manolaridis, I., Jackson, S. M., Taylor, N. M. I., Kowal, J., Stahlberg, H., & Locher, K. P. (2018) · Nature · doi:10.1038/s41586-018-0680-3 · Cited by 228 · cited 2×
“Upon ATP binding, the leucine plug is opened to allow substrate release.(29,30) Two molecules of more potent inhibitors, like MZ29, and a single molecule of a larger inhibitor, like MB136, can fill the complete binding cavity, locking the transporter in an inwardfacing conformation that prevents substrate access.”
BackgroundEnteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193 · cited 1×
“Interestingly, higher levels of several secondary bile acids in humans have been correlated with increased plasma concentrations of the cholesterol lowering drug, simvastatin.(88) These data suggest that secondary bile acids may decrease OATP1B1mediated simvastatin acid uptake in hepatocytes resulting in higher plasma…”
BackgroundType 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
Rusu, V., Hoch, E., Mercader, J. M., Tenen, D. E., Gymrek, M., Hartigan, C. R., DeRan, M., von Grotthuss, M., Fontanillas, P., Spooner, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.011 · Cited by 152 · cited 1×
“• Using GWAS for human disease and in particular associations of genetic polymorphisms in SLC16A11 with type 2 diabetes in Mexican subjects,(36) researchers identified pyruvate as a substrate of SLC16A11 explaining the mechanisms for the association with type 2 diabetes.(37) Recently, followup studies have shown that…”
BackgroundEpistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import
Girardi, E., Agrimi, G., Goldmann, U., Fiume, G., Lindinger, S., Sedlyarov, V., Srndic, I., Gürtl, B., Agerer, B., Kartnig, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19871-x · Cited by 123 · cited 2×
“The availability of a CRISPR- Cas9 library targeting 390 human SLC genes utlized by SupertiFurga and colleagues allowed genetic screening to elucidate SLC transporter function.(42,107) This resource has also been used successfully to determine cell cytotoxicity of various anti- cancer drugs upon targeting each of the…”
MethodBensimon, A., Pizzagalli, M. D., Kartnig, F., Dvorak, V., Essletzbichler, P., Winter, G. E., & Superti-Furga, G. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.04.003 · Cited by 102 · cited 3×
“The induced molecular proximity leads to polyubiquination of the transporter and subsequent degradation by the proteosome.(6) These proof of concept studies will undoubtedly lead to a new understanding of SLC transporter biology.”
BackgroundMethodBacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives
Zou, L., Spanogiannopoulos, P., Pieper, L. M., Chien, H.-C., Cai, W., Khuri, N., Pottel, J., Vora, B., Ni, Z., Tsakalozou, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920483117 · Cited by 61
Self-citation
Research works printed but not linked: 127
- 10.1002/cpt.1098 · DOI
- Bendayan R., 2022, Transporters in drug development: 2021 ITC update on emerging transporters of clinical importance., Clin. Pharmacol. Ther., 112, 485
- Brouwer K., Transcriptional and post‐transcriptional regulation of transporters, Clin. Pharmacol. Ther.
- 10.1124/dmd.118.082842 · DOI
- 10.1080/10245330701283991 · doi:10.1080/10245330701283991
- 10.1126/scitranslmed.3009318 · DOI · Paper page
- 10.1124/dmd.117.079277 · DOI
- 10.1016/j.jhep.2017.02.023 · DOI
- 10.1021/acs.molpharmaceut.9b01060 · doi:10.1021/acs.molpharmaceut.9b01060
- 10.1002/cpt.997 · DOI
- 10.2337/db18-0525 · DOI
- 10.1148/rycan.2019190035 · DOI
- 10.15252/msb.20209652 · DOI · Paper page
- 10.1002/cpt.1174 · DOI
- 10.1016/j.tips.2019.08.006 · DOI
- 10.1080/09687688.2018.1448123 · DOI · Paper page
- 10.1126/sciadv.abf5814 · DOI
- 10.1016/j.bbamem.2019.183154 · DOI
- 10.1038/s41586-021-03579-z · DOI · Paper page
- 10.1073/pnas.2104093118 · DOI · Paper page
- 10.3390/ijms22094806 · DOI · Paper page
- 10.1146/annurev-biochem-011520-105201 · DOI · Paper page
- 10.1073/pnas.2010264117 · DOI · Paper page
- 10.1126/science.aav7102 · DOI · Paper page
- 10.1126/science.aar7389 · DOI · Paper page
- 10.1038/s41467-021-24651-2 · DOI · Paper page
- 10.1038/s41594-018-0049-1 · DOI · Paper page
- 10.1021/acsinfecdis.7b00251 · DOI
- 10.1371/journal.pgen.1008208 · DOI · Paper page
- 10.1038/nature12828 · DOI · Paper page
- 10.1038/s42003-021-02279-8 · DOI
- 10.1016/j.celrep.2021.109025 · DOI · Paper page
- 10.1016/j.bcp.2017.12.012 · DOI
- 10.1038/d41573-020-00056-6 · DOI · Paper page
- 10.1515/hsz-2019-0148 · doi:10.1515/hsz-2019-0148
- 10.1002/1873-3468.13967 · DOI
- 10.1016/j.bbamem.2020.183336 · DOI · Paper page
- 10.3390/biom10040655 · DOI
- 10.3390/biom10121611 · DOI
- 10.1093/database/bat024 · DOI · Paper page
- 10.1021/acs.molpharmaceut.7b00728 · DOI
- 10.1152/ajpgi.90672.2008 · DOI
- 10.1021/acs.jmedchem.9b02119 · DOI
- 10.1007/978-1-4939-9136-5_18 · doi:10.1007/978-1-4939-9136-5_18
- 10.7554/eLife.50025 · DOI
- 10.1038/s41467-021-21451-6 · doi:10.1038/s41467-021-21451-6
- 10.1124/jpet.120.000309 · DOI
- 10.3324/haematol.2009.008631 · DOI · Paper page
- 10.1016/j.drup.2015.11.004 · DOI · Paper page
- 10.1093/intimm/dxab006 · DOI
- 10.1007/978-1-0716-0373-4_4 · DOI
- 10.1016/j.bbabio.2017.10.002 · DOI
- 10.1016/j.ajhg.2016.08.014 · DOI
- 10.1038/gim.2017.251 · DOI
- 10.1074/jbc.M513825200 · DOI · Paper page
- 10.1042/BST20190280 · DOI
- 10.1093/toxsci/kfx091 · DOI
- 10.1073/pnas.2020168118 · DOI
- 10.1093/toxsci/kfw021 · DOI
- 10.2174/138955751505150408142032 · DOI
- 10.1016/j.bcp.2015.11.019 · DOI
- 10.7150/thno.54936 · DOI
- 10.1021/acs.jmedchem.0c01570 · DOI
- 10.1002/cpt.1537 · DOI
- 10.1016/j.cbpa.2021.01.012 · DOI
- 10.1021/acschemneuro.7b00308 · DOI
- 10.1021/acsptsci.0c00102 · DOI
- 10.1016/j.pharmthera.2020.107785 · DOI
- 10.1371/journal.pone.0169719 · DOI · Paper page
- 10.1021/acs.molpharmaceut.6b00259 · DOI
- 10.1016/j.dmpk.2019.01.001 · DOI
- 10.1007/s00439-020-02237-0 · DOI · Paper page
- 10.1111/cts.13066 · DOI · Paper page
- 10.1111/cts.13132 · DOI
- 10.1002/psp4.12607 · DOI
- 10.1002/cpt.436 · DOI · Paper page
- 10.1124/dmd.118.082750 · DOI
- 10.7554/eLife.50135 · DOI · Paper page
- 10.1124/dmd.120.000098 · DOI
- 10.1016/j.addr.2018.09.009 · DOI
- 10.2337/dc21-1152 · DOI
- 10.1186/s13046-015-0275-x · DOI
- 10.1002/cpt.1128 · DOI
- 10.1038/ng.3632 · DOI · Paper page
- 10.1016/j.kint.2021.03.026 · DOI
- 10.1126/sciadv.1600800 · DOI
- 10.1124/dmd.120.000264 · DOI
- 10.1038/s41589-020-0483-3 · DOI · Paper page
- 10.1002/cpt.1216 · DOI · Paper page
- 10.1002/cpt.2022 · DOI
- 10.1002/cpt.2236 · DOI
- 10.1111/j.1365-2125.2011.03972.x · DOI
- 10.1016/S0140-6736(08)61343-4 · DOI · Paper page
- 10.1371/journal.pbio.2002907 · DOI
- 10.1002/cpt.1328 · DOI
- 10.3390/ijms21186466 · DOI · Paper page
- 10.1016/0092-8674(83)90040-5 · DOI · Paper page
- 10.1016/j.actbio.2018.12.045 · DOI · Paper page
- 10.1002/cpt.2102 · DOI
- 10.1002/cpt.2244 · DOI
- 10.1038/srep32299 · DOI
- 10.1002/hep.30927 · DOI · Paper page
- 10.1073/pnas.1312159110 · DOI · Paper page
- 10.1002/cpt.1183 · DOI
- 10.1101/2021.11.03.465409 · DOI
- 10.1038/s41586-021-03274-z · DOI · Paper page
- 10.1038/s41421-021-00247-4 · DOI · Paper page
- 10.1038/s42003-021-01750-w · DOI
- 10.1038/s41422-020-00437-x · doi:10.1038/s41422-020-00437-x
- 10.1038/s41586-021-03230-x · DOI
- 10.1126/sciadv.abk3259 · DOI · Paper page
- 10.1016/j.cell.2020.11.043 · DOI · Paper page
- 10.1007/978-1-4939-6949-4_12 · DOI
- 10.3389/fbioe.2020.577656 · DOI · Paper page
- 10.1038/s41598-020-78359-2 · DOI · Paper page
- 10.1016/j.bbrc.2021.06.007 · DOI
- 10.1093/toxsci/kft021 · DOI · Paper page
- 10.1016/j.isci.2021.103235 · DOI
- 10.1002/term.2802 · DOI · Paper page
- 10.3109/00498254.2014.944612 · DOI · Paper page
- 10.1111/cts.12969 · DOI · Paper page
- 10.1016/j.xphs.2021.01.028 · DOI · Paper page
- 10.1208/s12248-018-0247-0 · DOI · Paper page
- 10.1021/acs.molpharmaceut.9b00681 · DOI
- 10.3390/cells9040994 · DOI
- 10.1002/btm2.10126 · DOI · Paper page
- 10.1016/j.biomaterials.2022.121525 · DOI
Cited by
Predicting substrates for orphan solute carrier proteins using multi-omics datasets
Zhang, Y., Newstead, S., & Sarkies, P. (2025) · BMC Genomics · doi:10.1186/s12864-025-11330-5 · Cited by 6
Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates
Yee, S. W., Ferrández-Peral, L., Alentorn-Moron, P., Fontsere, C., Ceylan, M., Koleske, M. L., Handin, N., Artegoitia, V. M., Lara, G., Chien, H.-C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48569-7 · Cited by 4
Self-citationIlluminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
Giacomini, K., Yee, S. W., Ferrández-Peral, L., Alentorn, P., Fontsere, C., Ceylan, M., Koleske, M., Handin, N., Artegoitia, V., Lara, G., et al. (2023) · doi:10.21203/rs.3.rs-3263845/v1 · Cited by 1
Self-citationIlluminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
(2023) · doi:10.1101/2023.08.08.552553
Metadata
- Authors
- Giacomini, K. M., Yee, S. W., Koleske, M. L., Zou, L., Matsson, P., Chen, E. C., Kroetz, D. L., Miller, M. A., Gozalpour, E., & Chu, X.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2022-05-20
- Volume
- 112
- Issue
- 3
- Pages
- 540-561
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W4225129696
- Cited by
- 46
- References
- 22
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institutes of Health (GM117163, GM139875)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.